Arbor Rapha Capital Bioholdings I (Arbor Rapha Capital Bioholdings I) Forward Dividend Yield % : 0.00% (As of Jun. 14, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Arbor Rapha Capital Bioholdings I Forward Dividend Yield %?

As of today (2024-06-14), the Forward Annual Dividend Yield of Arbor Rapha Capital Bioholdings I is 0.00%.

As of today (2024-06-14), the Trailing Annual Dividend Yield of Arbor Rapha Capital Bioholdings I is 0.00%.

ARCK's Forward Dividend Yield % is not ranked ^*
in the Diversified Financial Services industry.
Industry Median: 3.595
* Ranked among companies with meaningful Forward Dividend Yield % only.

Arbor Rapha Capital Bioholdings I's Dividends per Share for the three months ended in Sep. 2022 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Arbor Rapha Capital Bioholdings I's Forward Dividend Yield %

For the Shell Companies subindustry, Arbor Rapha Capital Bioholdings I's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arbor Rapha Capital Bioholdings I's Forward Dividend Yield % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Arbor Rapha Capital Bioholdings I's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Arbor Rapha Capital Bioholdings I's Forward Dividend Yield % falls into.

Arbor Rapha Capital Bioholdings I Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Arbor Rapha Capital Bioholdings I (NAS:ARCK) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Arbor Rapha Capital Bioholdings I Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Arbor Rapha Capital Bioholdings I's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Arbor Rapha Capital Bioholdings I (Arbor Rapha Capital Bioholdings I) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Arbor Rapha Capital Bioholdings Corp I (NAS:ARCK) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

333 Earle Ovington Boulevard, Suite 900, Uniondale, NY, USA, 11553

Website

https://arcbiocorp.com

Arbor Rapha Capital Bioholdings Corp I is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

Executives

Ralph Mack	director	333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
Kevin M. Slawin	director, officer: Chief Strategy Officer	C/O BELLICUM PHARMACEUTICALS, INC., 2130 W. HOLCOMBE BLVD., STE. 800, HOUSTON TX 77030
Ivan Kaufman	director, 10 percent owner, officer: Chief Executive Officer
Arbor Commercial Mortgage Llc	director, 10 percent owner, officer: Chief Executive Officer	333 EARLE OVINGTON BLVD, STE 900, UNIONDALE NY 11553
Paul Elenio	officer: Chief Financial Officer	C/O ARBOR REALTY TRUST, 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
John Natalone	officer: Treasurer	C/O ARBOR REALTY TRUST, INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
William P Connolly	officer: Secretary & Vice President	C/O ARBOR REALTY TRUST INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553
Cyrus D. Walker	director	C/O MARIPOSA CAPITAL, LLC, 500 SOUTH POINTE DRIVE, SUITE 240, MIAMI BEACH FL 33139
Arbor Rapha Capital Llc	director, 10 percent owner, officer: Chief Executive Officer	333 EARLE OVINGTON BLVD., SUITE 900, UNIONDALE NY 11553
Avery Modlin	director	C/O ARBOR REALTY TRUST INC., 333 EARLE OVINGTON BOULEVARD, SUITE 900, UNIONDALE NY 11553

Arbor Rapha Capital Bioholdings I (Arbor Rapha Capital Bioholdings I) Headlines

From GuruFocus

Arbor Rapha Capital Bioholdings Corp. I Announces Closing of $172.5 Million Initial Public Offering

By PRNewswire PRNewswire • 11-02-2021

Arbor Rapha Capital Bioholdings Corp. I Announces the Separate Trading of its Shares of Class A Common Stock and Redeemable Warrants Commencing December 20, 2021

By PRNewswire PRNewswire • 12-17-2021